The DOI matches its Crossref record.
Prospective Study of Serum γ-Glutamyltransferase and Risk of NIDDM
Abstract
OBJECTIVE: Serum gamma-glutamyltransferase (GGT) levels are raised in obese individuals, and a particularly strong association with central obesity has been described. We hypothesized that elevated GGT levels are a marker for visceral fat, and specifically for hepatic steatosis (fatty liver), and that hepatic steatosis leads to hepatic insulin resistance. To test this hypothesis, we examined the association between GGT levels and risk of NIDDM. RESEARCH DESIGN AND METHODS: We carried out a prospective cohort study of incident cases of doctor-diagnosed NIDDM in a group of 7,458 nondiabetic men (aged 40-59 years) followed for a mean of 12.8 years (range 11.5-13.0). The men were randomly selected from general practice lists in 24 British towns. Cases of NIDDM were ascertained by repeated postal questionnaires to the men and by regular systematic review of primary care records. RESULTS: A total of 194 men developed NIDDM during follow-up. Mean serum GGT at baseline (geometric mean [95% CI]) was significantly higher in the NIDDM patients than in the rest of the cohort (20.9 [19.3-22.6] vs. 15.3 U/l [15.0-15.6], P < 0.0001). There was a smooth, graded increase in the age-adjusted risk of NIDDM with increasing GGT levels, with a relative risk in the top fifth of the distribution of 6.8 (3.5-12.9) relative to the bottom fifth (trend P < 0.0001). This association was independent of serum glucose and BMI and of other predictors of NIDDM with which GGT is associated, including alcohol intake and physical activity level (adjusted upper to lower fifth relative risk: 4.8 [2.0-11.8], trend P < 0.0001]). CONCLUSIONS: These findings suggest that a raised serum GGT level is an independent risk factor for NIDDM. Serum GGT level may be a simple and reliable marker of visceral and hepatic fat and, by inference, of hepatic insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“N onalcoholic fatty liver disease (NAFLD) precedes and predicts type 2 diabetes.[1][2][3][4][5][6]”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [3]
Citations
Cited by
Sorted by citations
Items 201–300 of 321
Baumeister, S. E., Völzke, H., Marschall, P., John, U., Fleßa, S., & Alte, D. (2008) · Cited by 13
Ghezelbash, B., Shahrokhi, N., Khaksari, M., et al. (2020) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2019-0040 · Cited by 13
Association of elevated alanine aminotransferase with BMI and diabetes in older veteran outpatients
Hermos, J. A., Cohen, S. A., Hall, R. B., GAGNON, D. R., Brophy, M. T., & Fiore, L. D. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.11.008 · Cited by 13
Potential Role of Interleukin‐18 in Liver Disease Associated with Insulin Resistance
López‐Bermejo, A., Bosch, M., Recasens, M., Biarnés, J., Esteve, E., Casamitjana, R., Vendrell, J. J., Ricart, W., & Fernández‐Real, J. M. (2005) · Obesity Research · doi:10.1038/oby.2005.237 · Cited by 13
Botton, J., Heude, B., Andre, P., Bresson, J., Ducimetière, P., & Charles, M.-A. A. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.03.008 · Cited by 12
Circulating Soluble CD14 Monocyte Receptor Is Associated with Increased Alanine Aminotransferase
Fernández‐Real, J. M., López‐Bermejo, A., Broch, M., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.030015 · Cited by 12
Turgut, O. O., Yılmaz, M. B., Yalta, K., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.019 · Cited by 12
Hernández-Muñoz, R. E., Olguín-Martínez, M., Aguilar-Delfín, I., et al. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/657387 · Cited by 11
Tokat, B., Demirci, D. K., Gül, N., Satman, İ., Öztürk, O., Özder, A., Küçükhüseyin, Ö., & Yılmaz, H. (2020) · Gene · doi:10.1016/j.gene.2020.145058 · Cited by 12
Hsiao, J., Wang, C.-L., Hsia, P., Hsieh, M., Hsin, S., Lin, K., & Shin, S. (2007) · Pancreas · doi:10.1097/mpa.0b013e31811f44fd · Cited by 11
Çalışkan, M., Erdoğan, D., Güllü, H., Çiftçi, Ö., Yildirim, I., Baycan, S., Yı́ldı́rı́r, A., & Müderrisoğlu, H. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f05bf1 · Cited by 11
Non-Alcoholic Fatty Liver Disease Modifies Serum Gamma-Glutamyl Transferase in Cigarette Smokers
Oni, E., Figueredo, V. M., Aneni, E. C., et al. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3932 · Cited by 10
Elevated liver enzymes in women with a family history of diabetes
Inoue, K., Matsumoto, M., Miyoshi, Y., & Kobayashi, Y. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.10.032 · Cited by 10
“[3] I.”
BackgroundDoes bilirubin protect against developing diabetes mellitus?
Breimer, L. H., & Mikhailidis, D. P. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.01.019 · Cited by 10
“It should be noted that their findings of GGT are at variance to that reported by the British Regional Heart study [Perry et al. 1998].”
Kubota, R., Hayashi, N., Kinoshita, K., Saito, T., Ozaki, K., Ueda, Y., Tsuchishima, M., Tsutsumi, M., & George, J. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15258 · Cited by 10
Perseghin, G., Caumo, A., Lattuada, G., COBELLI, F. D., Ntali, G., Esposito, A., Belloni, E., Canu, T., Ragogna, F., Scifo, P., et al. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02785.x · Cited by 10
Lippi, G., Targher, G., & Guidi, G. C. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.091512 · Cited by 10
Seet, R. C. S., Quek, A. M. L., Lim, E. C. H., & Halliwell, B. B. (2013) · Free Radical Research · doi:10.3109/10715762.2013.769215 · Cited by 9
García‐Hermoso, A., Hackney, A. C., & Ramírez‐Vélez, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185908 · Cited by 9
Prevalence and Clinical Features of Hyperuricemia in Gwangju and Jeonnam Territories
Hong, S. J., Kim, Y. S., & Kim, H. (2012) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2012.19.3.138 · Cited by 9
Potential mechanisms underlying the associations between liver enzymes and risk for type 2 diabetes
Venkatesan, C., Younossi, Z. M., Groszmann, R. J., Iwakiri, Y., & Taddei, T. H. (2012) · Hepatology · doi:10.1002/hep.24769 · Cited by 9
Benini, F., Pigozzi, M. G., Pozzi, A., Bercich, L., Reggiani, A., Quattrocchi, D., Distefano, L., Donati, P., Cesana, B. M., & Lanzini, A. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2008.11.016 · Cited by 9
Ozturk, M., Keskin, U., Öztürk, Ö., Ulubay, M., Alanbay, İ., Aydin, A., & Yenen, M. C. (2016) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2016.1174827 · Cited by 9
“Furthermore, it has also been suggested that GGT is an indicator of visceral and hepatic fat (Perry et al. 1998).”
BackgroundIroezindu, M. O., Isiguzo, G. C., & Young, E. E. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.08.006 · Cited by 8
Lorzadeh, E., Akhondi‐Meybodi, M., Mozaffari–Khosravi, H., Mirzaei, M., & Salehi‐Abargouei, A. (2020) · Nutrition · doi:10.1016/j.nut.2020.110897 · Cited by 8
Murawska, A., Berbeć, E., Latarowski, K., Roman, A., & Migdał, P. (2025) · PLoS ONE · doi:10.1371/journal.pone.0309567 · Cited by 8
Comparison of gamma glutamyltransferase in normal and in type 2 diabetics.
Iqbal, A., Iftikhar, U., Ali, F. A., et al. (2010) · PubMed · Cited by 7
Wang, X., Liu, J., Wang, Q., & Chen, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1122047 · Cited by 9
Xu, Y., Xu, M., Huang, Y., Wang, T., Li, M., Wu, Y., Song, A., Li, X., Bi, Y., & Ning, G. (2011) · Endocrine · doi:10.1007/s12020-011-9468-z · Cited by 7
Shin, J., Hwang, J.-H., Jeong, J., et al. (2009) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.2009.42.6.386 · Cited by 7
“여러가지질병들중에서도특히향후 제 2형 당뇨병 발생 위험과 매우 강한 용 량-반응관계가 있었는데 이는 생리학적 범위내에서 혈청 GGT 증가에 관여할 수 있는어떠한요인들이제 2형당뇨병의발 생기전과밀접한관련성이있을가능성이 있음을시사한다 [4,5,7,8,10,12,13].”
InfluentialYu, J.-H., Kim, J. S., Lee, M.-R., et al. (2016) · Annals of Occupational and Environmental Medicine · doi:10.1186/s40557-016-0105-4 · Cited by 7
Lippi, G., Salvagno, G. L., Targher, G., et al. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.0810 · Cited by 7
Chitturi, S., & Farrell, G. C. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05977.x · Cited by 7
Gamma-glutamyl transpeptidase and the metabolic syndrome in a Taiwanese aboriginal population
Ho, C.-I., Tsao, Y.-C., Chen, J., Chang, K., Tsai, Y.-W., Lin, J.-S., & Chang, S.-S. (2013) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-013-0127-1 · Cited by 6
“Several population-based studies have reported positive associations between serum gamma glutamyl transferase (GGT), and incident cardiovascular events [3, 4] and risk factors for diabetes, in particular oxidative stress [5, 6] and nonalcoholic fatty liver disease (NAFLD) [7, 8].”
BackgroundYueh, C.-Y., Chen, J.-H., Lee, L., Lu, C., Parekh, B. K., & Chi, C. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.05.038 · Cited by 6
Can we use serum gamma-glutamyl transferase levels to predict early mortality in stroke?
Akıncı, E., Doğan, N. Ö., Gümüş, H., et al. (2014) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.303.4456 · Cited by 6
Bianchi, C., Penno, G., Crisci, I., Daniele, G., Agostini, A., Prato, S. D., & Miccoli, R. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1069 · Cited by 6
Longo‐Mbenza, B., Muaka, M. M., Mokondjimobé, E., et al. (2012) · PubMed · doi:10.3980/j.issn.2222-3959.2012.04.17 · Cited by 6
Han, K., Cho, D., Kim, Y., & Kim, K.-N. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.161343 · Cited by 6
Kaushik, G. G., Sharm, S., Sharma, R., & Mittal, P. (2009) · PubMed · Cited by 6
Successful treatment of obesity and insulin resistance via ketogenic diet status post Roux-en-Y
Handley, R. T., Ryan, B., Brown, T., & Annan, A. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-225643 · Cited by 7
Vuković, M., Lapčević, M., Kalezic, N. K., & Gvozdenović, B. (2007) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh0708447v · Cited by 6
Mabile, L., Ruidavets, J., Fauvel, J., Perret, B., & Ferrières, J. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1652 · Cited by 6
Modulating effect of soy protein on serum cardiac enzymes in cholesterol-fed rats
Saki, N., Saki, G., Rahim, F., et al. (2011) · International Journal of Medicine and Medical Sciences · doi:10.5897/ijmms.9000155 · Cited by 6
Serum gamma-glutamyl transferase level as a risk factor in acute stroke
Ismail, Q. M., Prasad, M. K., Marandi, S., et al. (2023) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_750_23 · Cited by 5
Cho, Y., Shin, M., & Chung, H.-K. (2014) · Clinical Nutrition Research · doi:10.7762/cnr.2014.3.2.106 · Cited by 5
Fujiyoshi, A., Miura, K., Hozawa, A., et al. (2010) · Global Heart · doi:10.1016/j.cvdpc.2010.03.003 · Cited by 5
Ko, H., Choi, C.-S., Youn, C., Lee, D., & Lee, S.-G. (2013) · The Korean Journal of Obesity · doi:10.7570/kjo.2013.22.1.21 · Cited by 5
Oh, M., Jung, S., Chae, S., Park, B., & Lee, S. (2023) · European Journal of Nutrition · doi:10.1007/s00394-022-03075-8 · Cited by 5
Huang, W., Xie, C., Albrechtsen, N. J. W., Sang, M., Sun, Z., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2023) · Peptides · doi:10.1016/j.peptides.2023.171092 · Cited by 5
Vital Capacity and Selected Metabolic Diseases in Middle‐Aged Japanese Men
Sakuta, H., Suzuki, T., Yyasuda, H., et al. (2006) · Canadian Respiratory Journal · doi:10.1155/2006/892034 · Cited by 5
Metabolic Syndrome and Inflammation
Pop‐Busui, R., & Pietropaolo, M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-478-4_5 · Cited by 5
Associação da gama-glutamil transferase e a síndrome metabólica em mulheres obesas
Araújo, L. M. B., Lima, D. S., & Daltro, C. (2005) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302005000400014 · Cited by 5
Jung, S., & Chae, S. (2018) · Journal of Nutrition and Health · doi:10.4163/jnh.2018.51.5.386 · Cited by 5
Kaido, T., Honda, Y., & Kitamura, K. (2002) · Journal of Occupational Health · doi:10.1539/joh.44.301 · Cited by 5
Mirea, O., Oghli, M. G., Neagoe, O., Berceanu, M. C., Țieranu, E. N., Moraru, L., Raicea, V. C., & Donoiu, I. (2025) · Diabetology · doi:10.3390/diabetology6010005 · Cited by 4
“GGT has been identified as a marker of oxidative stress, and the association between increased plasma levels of GGT and the risk of developing DM [31,32], as well as the risk for mortality in already diagnosed patients, has been described [33].”
Yueh, C.-Y., Yang, Y., Sung, Y., et al. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0389 · Cited by 4
“Besides metabolic syndrome features, hepatocytic enzymes are ones of the most frequently-identified laboratory parameters associated with insulin resistance [11-17].”
BackgroundResultYokoyama, H., Ohgo, H., Hirose, H., et al. (2006) · Journal of Occupational Health · doi:10.1539/joh.48.198 · Cited by 4
Amarapurkar, D. N., Patel, N. D., & Kamani, P. M. (2008) · Hepatitis Monthly · Cited by 4
Özdemir, M., DAĞ, Y., Uzunlulu, M., Oğuz, A., Ardagil, A., Acar, Ö., & SELBEST, B. (2024) · Pamukkale Medical Journal · doi:10.31362/patd.1419095 · Cited by 3
Liang, S., & Yang, T. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s475067 · Cited by 4
Oxidative Stress in Metabolic Syndrome
Simão, A. C., Lovozoy, M. A. B., & Dichi, I. (2014) · CRC Press eBooks · doi:10.1201/b16653-15 · Cited by 3
Nonalcoholic Fatty Liver Disease
Stefan, N., & Häring, H. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50024-3 · Cited by 3
Risk factors and blood-borne biochemical markers in type 2 diabetes mellitus
Kappala, S. S. (2012) · CLOK (University of Central Lancashire) · Cited by 3
Onabanjo, O. (2013) · Cited by 2
Risk factors and carotid atherosclerosis in hypertensive and control subjects
Rantala, A. O. (2001) · Cited by 2
Khatun, M. A., Prodhan, U. K., & Rahman, N. (2017) · International Journal of Advanced Research in Biological Sciences (IJARBS) · doi:10.22192/ijarbs.2017.04.03.020 · Cited by 2
(2020) · The Journal of Animal and Plant Sciences · doi:10.36899/japs.2020.4.0095 · Cited by 2
Hashimoto, Y., & Futamura, A. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.01.025 · Cited by 2
Transaminases profile in Algerian patients with type 2 diabetes mellitus
Gouri, A., Dekaken, A., Rouabhia, S., et al. (2012) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/j.immbio.2012.07.021 · Cited by 2
Yamada, Y., Noborisaka, Y., Ishizaki, M., Tsuritani, I., & Honda, R. (2004) · Environmental Health and Preventive Medicine · doi:10.1007/bf02898137 · Cited by 2
Coffee and Risk of Type 2 Diabetes
Bidel, S., & Tuomilehto, J. (2007) · Työväentutkimus Vuosikirja · Cited by 2
The Prothrombotic Syndrome in Type 2 Diabetes: Assessment and Control
Cucuianu, M., & Coca, M. (2003) · Springer eBooks · doi:10.1007/978-3-642-59352-9_14 · Cited by 1
Teng, C., He, L., Xu, J., et al. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s581025 · Cited by 1
Gu, M., Niu, N., Liao, Y., Hu, H., & Gu, D. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1704211 · Cited by 1
“The early longitudinal investigations examining the relationship between NAFLD biomarkers and diabetes risk were published in 1998 (16).”
Shi, L.-M., Gao, Y.-X., Yang, J.-Q., et al. (2026) · Vascular Health and Risk Management · doi:10.2147/vhrm.s560291 · Cited by 1
Arase, Y., Heianza, Y., Hara, S., Ohmoto‐Sekine, Y., Amakawa, K., Tsuji, H., Ogawa, K., Saito, K., Kodama, S., Ikeda, K., et al. (2014) · Hepatology Research · doi:10.1111/hepr.12343 · Cited by 1
The Effect of Gamma-Glutamyltransferase on Impaired Fasting Glucose or Type 2 Diabetes in Korean Men
Kim, T.-Y., Kim, D., Park, C.-H., et al. (2009) · Korean Diabetes Journal · doi:10.4093/kdj.2009.33.3.215 · Cited by 1
The Association between Elevated GGT with Alcohol Consumption and with Insulin Resistance
Bae, M. J., Oh, I. H., Park, J. S., Lee, S. Y., Lee, J. G., Kim, Y. J., Jung, D.-W., Yi, Y. H., Cho, Y. H., & Choi, E. J. (2011) · The Korean Journal of Obesity · doi:10.7570/kjo.2011.20.3.113 · Cited by 1
The Contribution of Different Risk Factors in the Occurrence of Stroke
Barnes, P. (2014) · American Journal of Health Research · doi:10.11648/j.ajhr.20140206.21 · Cited by 1
이장훈, 채성철, 이현상, et al. (2007) · The Korean Journal of Internal Medicine · Cited by 1
이건호 (2009) · JOURNAL OF THE KOREAN SOCIETY OF MATERNAL AND CHILD HEALTH · doi:10.21896/jksmch.2009.13.2.171 · Cited by 1
Maiti, S., & Kumar, A. (2017) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v8i3.16766 · Cited by 1
Singh, V., Tiwari, S., Singh, S., et al. (2020) · International Journal of Contemporary Medical Research [IJCMR] · doi:10.21276/ijcmr.2020.7.1.10 · Cited by 1
Fan, Y., Pu, Y., Xu, X., & Yang, J. (2025) · Nutrition and Health · doi:10.1177/02601060251357979 · Cited by 2
“Diet adjustments and lifestyle modi fi - cations are the cornerstone of NAFLD management strategies for managing NAFLD (Perry et al., 1998).”
고혈압 및 당뇨병 환자에서 한식 섭취가 혈청 GGT와 심혈관질환 위험인자에 미치는 영향
정수진, & 채수완 (2018) · Journal of Nutrition and Health · Cited by 1
Yamada, Y., Noborisaka, Y., Ishizaki, M., et al. (2004) · Environmental Health and Preventive Medicine · doi:10.1265/ehpm.9.243 · Cited by 1
Dan, S., Aditya, P., Banerjee, P., Musfikur, R., Roy, H., Roy, A. S., & Jana, T. (2014) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v4i1.753
Prithwijit, B., Roy, H., Dan, S., Musfikur, R., & Roy, A. (2014) · Journal of Drug Discovery and Therapeutics
LIVER FAT IN THE METABOLIC SYNDROME AND TYPE 2 DIABETES
Kotronen, A. (2008) · Työväentutkimus Vuosikirja
Lim, J. S., Choi, Y. H., Jeong, J. Y., Jang, S., Moon, Y. S., Kim, J.-H., Kwak, E. S., Choi, M. G., Hong, K.-S., & Kim, D. H. (2009) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2009.30.1.23
Choi, M. S., Bae, T. W., Lee, J., et al. (2013) · Laboratory Medicine Online · doi:10.3343/lmo.2013.3.1.15
“그러나 최근 연구에 따르면 혈중 GGT 농도가 알코올 섭취나 간담도계의 질환 등과 관계없이 심혈 관계 질환의 위험요소, 대사증후군의 구성요소, 당뇨병의 발병위 험, 뇌졸중, 심장관련 치사율(cardiac mortality) 및 비치명적 심근 경색증(nonfatal myocardial infarction) 등과 뚜렷한 용량-반응관 계를 나타내며[1-7], 또한 퇴행성 인조질환(degenerative and manmade diseases)의 발생 위험을 예측할 수 있다고 보고하고 있다[8].”
Feasibility of Multiparametric Screening for Glucose Tolerance
Ognibene, A., Mannucci, E., Brogi, M., Sposato, I., Terreni, A., Cremasco, F., Cremasco, F., Messeri, G., & Rotella, C. M. (2006) · Laboratory Medicine · doi:10.1309/1uvaq6r85njy6043
Lim, S. K. (2008) · Korean Diabetes Journal · doi:10.4093/kdj.2008.32.5.462
Neto, A. S., Rossi, F. M. B., Amarante, R. D. M., & Rossi, M. (2011) · Einstein (São Paulo) · doi:10.1590/s1679-45082011ao2042
Moors, J. (2016) · Otago University Research Archive (University of Otago)
Kwon, S. Y., & Na, Y. (2016) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2016.48.1.22
Heidemann, C. (2006) · DepositOnce · doi:10.14279/depositonce-1451
“deren Beitrag zu einer erhöhten Energieaufnahme [149-151], zu Störungen im Glukosemetabolismus [152-154] sowie zu einer verschlechterten Leberfunktion [155] diskutiert.”
BackgroundRelationship between Exercise and Gamma-Glutamyltransferase in Korean
Son, H.-J., Kim, S. Y., Chun, S., et al. (2016) · Korean Journal of Family Practice · doi:10.21215/kjfp.2016.6.1.8
Metadata
- Authors
- Perry, I. J., Wannamethee, S. G., & Shaper, A. G.
- Affiliations
- The Royal Free Hospital (GB)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1998-05-01
- Volume
- 21
- Issue
- 5
- Pages
- 732-737
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2146589543
- Cited by
- 319
- References
- 0
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 2 · 2021: 2 · 2020: 10 · 2019: 1 · 2018: 8 · 2017: 10 · 2016: 14 · 2015: 5 · 2014: 15 · 2013: 13 · 2012: 18
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- gamma-glutamyl transferase, type 2 diabetes, type 2 diabetes risk, hepatic steatosis, visceral fat, hepatic insulin resistance, biomarkers, alcohol consumption, physical activity, obesity, men
- MeSH terms
- Adult, Alcohol Drinking, Alkaline Phosphatase, Aspartate Aminotransferases, Diabetes Mellitus, Type 2, Follow-Up Studies, gamma-Glutamyltransferase, United Kingdom, Humans, Liver, Male, Middle Aged, Obesity, Predictive Value of Tests, Prospective Studies, Risk Factors, Body Mass Index, Incidence, Multivariate Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review